GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Intravenous Infusions Ltd (XGHA:IIL) » Definitions » Research & Development

Intravenous Infusions (XGHA:IIL) Research & Development : GHS Mil (TTM As of . 20)


View and export this data going back to 2015. Start your Free Trial

What is Intravenous Infusions Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Intravenous Infusions's Research & Development for the six months ended in . 20 was GHS0.00 Mil. Intravenous Infusions does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in . 20.


Intravenous Infusions Research & Development Historical Data

The historical data trend for Intravenous Infusions's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intravenous Infusions Research & Development Chart

Intravenous Infusions Annual Data
Trend
Research & Development

Intravenous Infusions Semi-Annual Data
Research & Development

Intravenous Infusions Research & Development Calculation

This is the expense the company spent on research and development.


Intravenous Infusions  (XGHA:IIL) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Intravenous Infusions Research & Development Related Terms

Thank you for viewing the detailed overview of Intravenous Infusions's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Intravenous Infusions (XGHA:IIL) Business Description

Traded in Other Exchanges
N/A
Address
Plot 4/7 Blk L, P.O Box KF 63, Effiduase-Koforidua, GHA
Intravenous Infusions Ltd engages in the production of intravenous infusion and small-volume injectables for therapeutic purposes. The product categories are IV fluids, giving sets, and small-volume injectables. The company earns a majority of its revenue from IV fluids. Some of the IV fluids are sodium chloride solutions, dextrose solutions, dextrose saline solutions, and dextran solutions. Small-volume injectables include pethidine injection, magnesium sulphate injection, and quinine injection. Giving sets include plain giving sets, and blood giving sets.

Intravenous Infusions (XGHA:IIL) Headlines